Sommadossi Jean-Pierre

Track

Insider profile

Performance

Overall performance
3.7
Performance over holding periods
3.7
30 days 90 days 120 days
Average return 7% 8.2% 15.1%
Success rate 100% 68% 82%
Transactions
4 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Sommadossi Jean-Pierre's trades of Atea Pharmaceuticals Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Sale
Price
4.00
Quantity 1,006 -0.0%
Value US$4,024
Transaction date
Proposed sale
Price
4.07
Quantity 65,476
Value US$266,487
Transaction date
Purchase
Price
14.00
Quantity 6,364 +0.3%
Value US$89,096
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2024-09-19 2024-09-19
S Sale
56,004 -40.7%
432.19
US$4,400,857 		56,004 -40.7% 432.19 US$4,400,857
2024-09-19 2024-09-18
S Sale
68,300 -19.9%
56.35
US$2,834,076 		68,300 -19.9% 56.35 US$2,834,076
2024-09-19 2024-09-17
S Sale
33,247 +21.2%
286.88
US$2,645,721 		33,247 +21.2% 286.88 US$2,645,721
2024-06-07 2024-06-05
S Sale
1,006 -0.0%
4.00
US$4,024 		1,006 -0.0% 4.00 US$4,024
2024-02-02 2024-02-01
PlS Planned sale
56,910 -32.8%
3.85
US$218,819 		56,910 -32.8% 3.85 US$218,819
2024-02-01 2024-02-01
PrS Proposed sale
65,476
4.07
US$266,487 		65,476 4.07 US$266,487
2004-07-29 2004-07-27
B Purchase
6,364 +0.3%
14.00
US$89,096 		6,364 +0.3% 14.00 US$89,096